Use of anthropometric measures to predict insulin resistance;Utilización de mediciones antropométricas para predecir resistencia a la insulina

Endocrinologia y Nutricion

Volumn 55, Issue 2, 2008, Pages 69-77

  García, Saúl Suárez ^a   González, Luis Díaz ^a   Álvarez Cosmea, Artemio ^a   Fernández, Vicente López ^a   García, María Teresa Arias ^a   Díaz, Miguel Ángel Prieto ^b  

^a Centro de Salud Ventanielles Colloto   (Spain)

^b Centro de Salud Vallobin   (Spain)

Author keywords

Diagnostic procedures and techniques; Epidemiology; Insulin resistance; Obesity

Indexed keywords

INSULIN;

ADULT; AGED; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BIOCHEMISTRY; BODY MASS; BODY SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULINEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREDICTION; PROBABILITY; RANDOM SAMPLE; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; WAIST HIP RATIO;

EID: 39449107744     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(08)70639-9     Document Type: Article

References (30)

1. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121-31.
2. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514-20.
3. Stern MP. The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia. 1994;37:956-8.
4. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-304.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
6. Reaven GM. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004;33:283-303.
7. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care. 2003;26:3153-9.
8. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
9. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet Med. 1998;15:539-53.
10. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.
11. National Institutes of Health. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Full Report. Bethesda: National Institutes of Health. National Heart, Lung, and Blood Institute; 2002.
12. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American Collegue of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-52.
13. International Diabetes Federation. Worldwide definition of the metabolic syndrome [citado Dic 2006]. Disponible en: http://www.idf.org/webdata/docs/ IDF_Metasyndrome_definition.pdf
14. Seidell JC, Cigolini M, Charzewska J, Contaldo F, Ellsinger BM, Björntorp P. Measurement of regional distribution of adipose tissue. En: Björntorp P, Rösner S, editores. Obesity in Europe 88. Proceedings of the 1st European Congress on Obesity. Estocolmo: John Libbey; 1988. p. 351-7.
15. Matthews DR, Hosker JP, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
16. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Geneva: Department of Noncommunicable Disease Surveillance, World Health Organization; 1999.
17. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ. 2005;330:1363-4.
18. a ed. New York: John Wiley & Sons; 1981. p. 14-5.
19. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-43.
21. Feinstein AR. Clinical biostatistics. XXXI. On the sensitivity, specificity and discrimination of diagnostic tests. Clin Pharmacol Ther. 1975;17:104-16.
22. How good is that test-using results. Vol. 3. Oxford: Bandolier; 1996. p. 6-8.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23.
24. Matthews DR, Hosker JP, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
25. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320-5.
26. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643-9.
27. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinem H. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care. 1996;19:1138-41.
28. Clinical guidelines on the identification; evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res. 1998;6:S51-209.
29. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome. Diabetes. 2004;53:2087-94.
30. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply The National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27:1182-6.